Takeda Raises ¥1.2 Trillion, Fuels R&D in Oncology, Autoimmune, and Rare Diseases
Takeda raises ¥1.2 trillion to fuel a high‑investment R&D pipeline across oncology, autoimmune, rare disease and neurology, boosting shareholder confidence and market share.
4 minutes to read